Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants.

AIM: To test for immunologic noninferiority of antibody responses to Hib and MenC using a 6-in-1 combination vaccine (DTPa-IPV/Hib-MenC-TT) compared with DTPa-IPV-Hib plus MenC-CRM197, before and after a 12-month Hib-MenC-TT booster. METHODS: Pragmatic open-label, randomized, multicenter, UK study....

Cijeli opis

Bibliografski detalji
Glavni autori:	Khatami, A, Snape, MD, Ohene-Kena, B, Young, K, Oeser, C, Michaelis, L, Macleod, E, Smee, H, Van Der Meeren, O, Leyssen, M, Caubet, M, Yu, L, Heath, P, Faust, SN, Finn, A, Pollard, A
Format:	Journal article
Jezik:	English
Izdano:	2013

Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants.

Slični predmeti